Polygenic Risk Scores and Hearing Loss Phenotypes in Children.

IF 6 1区 医学 Q1 OTORHINOLARYNGOLOGY JAMA otolaryngology-- head & neck surgery Pub Date : 2024-11-07 DOI:10.1001/jamaoto.2024.3659
Jing Wang, Fan He, Daisy A Shepherd, Shuai Li, Katherine Lange, Valerie Sung, Angela Morgan, Jessica A Kerr, Richard Saffery, Melissa Wake
{"title":"Polygenic Risk Scores and Hearing Loss Phenotypes in Children.","authors":"Jing Wang, Fan He, Daisy A Shepherd, Shuai Li, Katherine Lange, Valerie Sung, Angela Morgan, Jessica A Kerr, Richard Saffery, Melissa Wake","doi":"10.1001/jamaoto.2024.3659","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Monogenic causes of childhood hearing loss are well established, as are polygenic risk contributions to age-related hearing loss. However, an untested possibility is that polygenic risk scores (PRS) also contribute to childhood hearing loss of all severities, alongside environmental and/or monogenic causes.</p><p><strong>Objective: </strong>To examine the association between a PRS for adult hearing loss and childhood hearing loss phenotypes.</p><p><strong>Design, setting, and participants: </strong>This cross-sectional study used a unique population-based dataset spanning normal hearing to profound loss, combining 2 contemporaneous population cohorts in Australia. This included the Child Health CheckPoint, a national population-based cross-sectional study nested within the Longitudinal Study of Australian Children, and the Victorian Childhood Hearing Longitudinal Databank (VicCHILD), a statewide population-based longitudinal data bank open to every child with congenital hearing loss in Victoria, Australia. The analysis took place from March to August 2023.</p><p><strong>Exposures: </strong>Genotype data were generated from saliva- or blood-derived DNA using global single-nucleotide variations arrays. Based on genotype data, PRS was computed using published UK Biobank genome-wide association study results for self-reported hearing difficulty in individuals aged 40 to 69 years.</p><p><strong>Main outcomes and measures: </strong>Hearing outcomes were classified by laterality (bilateral, unilateral), severity (mild, moderate, severe or worse) and types (sensorineural, conductive, mixed, auditory neuropathy, atresia). Analyses included multinominal logistic regressions of PRS with hearing outcomes.</p><p><strong>Results: </strong>Overall, 1488 CheckPoint study children (49.8% boys, aged 11-12 years) and 527 VicCHILD study children (55.2% boys, aged 0-13 years) with hearing and genotype data were included. A 1-SD increment in PRS was associated with higher odds of mild (odds ratio [OR], 1.3; 95% CI, 1.0-1.6), moderate (OR, 5.1; 95% CI, 3.2-8.1), and severe or worse (OR, 5.3; 95% CI, 3.9-7.3) unilateral hearing loss compared with normal hearing. Similarly, the PRS was associated with increased odds of mild, moderate, and severe or worse bilateral hearing loss (per-SD ORs, 3.9-6.6) and all hearing loss types (per-SD ORs, 8.5-10.6).</p><p><strong>Conclusions and relevance: </strong>In this cross-sectional study, a PRS initially developed for adult hearing difficulty was associated with wide-ranging childhood hearing loss phenotypes, partly explaining hearing phenotype variations despite shared genetic and environmental factors (eg, preterm birth). Large-scale studies with objectively defined hearing phenotypes are crucial for refining PRS and predicting high-risk children.</p>","PeriodicalId":14632,"journal":{"name":"JAMA otolaryngology-- head & neck surgery","volume":" ","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544553/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA otolaryngology-- head & neck surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamaoto.2024.3659","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Importance: Monogenic causes of childhood hearing loss are well established, as are polygenic risk contributions to age-related hearing loss. However, an untested possibility is that polygenic risk scores (PRS) also contribute to childhood hearing loss of all severities, alongside environmental and/or monogenic causes.

Objective: To examine the association between a PRS for adult hearing loss and childhood hearing loss phenotypes.

Design, setting, and participants: This cross-sectional study used a unique population-based dataset spanning normal hearing to profound loss, combining 2 contemporaneous population cohorts in Australia. This included the Child Health CheckPoint, a national population-based cross-sectional study nested within the Longitudinal Study of Australian Children, and the Victorian Childhood Hearing Longitudinal Databank (VicCHILD), a statewide population-based longitudinal data bank open to every child with congenital hearing loss in Victoria, Australia. The analysis took place from March to August 2023.

Exposures: Genotype data were generated from saliva- or blood-derived DNA using global single-nucleotide variations arrays. Based on genotype data, PRS was computed using published UK Biobank genome-wide association study results for self-reported hearing difficulty in individuals aged 40 to 69 years.

Main outcomes and measures: Hearing outcomes were classified by laterality (bilateral, unilateral), severity (mild, moderate, severe or worse) and types (sensorineural, conductive, mixed, auditory neuropathy, atresia). Analyses included multinominal logistic regressions of PRS with hearing outcomes.

Results: Overall, 1488 CheckPoint study children (49.8% boys, aged 11-12 years) and 527 VicCHILD study children (55.2% boys, aged 0-13 years) with hearing and genotype data were included. A 1-SD increment in PRS was associated with higher odds of mild (odds ratio [OR], 1.3; 95% CI, 1.0-1.6), moderate (OR, 5.1; 95% CI, 3.2-8.1), and severe or worse (OR, 5.3; 95% CI, 3.9-7.3) unilateral hearing loss compared with normal hearing. Similarly, the PRS was associated with increased odds of mild, moderate, and severe or worse bilateral hearing loss (per-SD ORs, 3.9-6.6) and all hearing loss types (per-SD ORs, 8.5-10.6).

Conclusions and relevance: In this cross-sectional study, a PRS initially developed for adult hearing difficulty was associated with wide-ranging childhood hearing loss phenotypes, partly explaining hearing phenotype variations despite shared genetic and environmental factors (eg, preterm birth). Large-scale studies with objectively defined hearing phenotypes are crucial for refining PRS and predicting high-risk children.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多基因风险评分和儿童听力损失表型。
重要性:儿童听力损失的单基因病因已得到公认,多基因风险也是导致老年性听力损失的原因之一。然而,一种未经检测的可能性是,多基因风险评分(PRS)也会导致各种严重程度的儿童听力损失,同时环境和/或单基因原因也会导致儿童听力损失:目的:研究成人听力损失风险评分与儿童听力损失表型之间的关联:这项横断面研究使用了一个独特的基于人口的数据集,该数据集涵盖了从正常听力到极重度听力损失的各个阶段,并结合了澳大利亚的两个同期人口队列。这包括 "儿童健康检查点"(Child Health CheckPoint)和维多利亚州儿童听力纵向数据库(VicCHILD),前者是澳大利亚儿童纵向研究(Longitudinal Study of Australian Children)中嵌套的一项全国性人群横断面研究,后者则是一个面向澳大利亚维多利亚州所有先天性听力损失儿童的全州人群纵向数据库。分析时间为 2023 年 3 月至 8 月:基因型数据是利用全球单核苷酸变异阵列从唾液或血液中提取的 DNA 生成的。根据基因型数据,利用已公布的英国生物库全基因组关联研究结果,计算出40至69岁个体自述听力困难的PRS:听力结果按偏侧(双侧、单侧)、严重程度(轻度、中度、重度或更严重)和类型(感音神经性、传导性、混合性、听神经病变、闭锁)分类。分析包括 PRS 与听力结果的多项式逻辑回归:共纳入了 1488 名 CheckPoint 研究儿童(49.8% 为男孩,年龄为 11-12 岁)和 527 名 VicCHILD 研究儿童(55.2% 为男孩,年龄为 0-13 岁)的听力和基因型数据。与听力正常的儿童相比,PRS 每增加 1 个标准差,轻度(几率比 [OR],1.3;95% CI,1.0-1.6)、中度(OR,5.1;95% CI,3.2-8.1)和重度或更严重(OR,5.3;95% CI,3.9-7.3)单侧听力损失的几率就会增加。同样,PRS 与轻度、中度和重度或更严重的双侧听力损失(每标本 ORs,3.9-6.6)和所有听力损失类型(每标本 ORs,8.5-10.6)的几率增加有关:在这项横断面研究中,最初针对成人听力困难而开发的听力损失预测模型与广泛的儿童听力损失表型相关,部分解释了尽管存在共同的遗传和环境因素(如早产)但听力表型的变化。利用客观定义的听力表型进行大规模研究对于完善听力损失预测系统和预测高风险儿童至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.10
自引率
5.10%
发文量
230
期刊介绍: JAMA Otolaryngology–Head & Neck Surgery is a globally recognized and peer-reviewed medical journal dedicated to providing up-to-date information on diseases affecting the head and neck. It originated in 1925 as Archives of Otolaryngology and currently serves as the official publication for the American Head and Neck Society. As part of the prestigious JAMA Network, a collection of reputable general medical and specialty publications, it ensures the highest standards of research and expertise. Physicians and scientists worldwide rely on JAMA Otolaryngology–Head & Neck Surgery for invaluable insights in this specialized field.
期刊最新文献
Immune Checkpoint Inhibitors for Head and Neck Squamous Cell Carcinoma-Reply. Lobectomy vs Total Thyroidectomy With Ipsilateral Lateral Neck Dissection for N1b Intermediate-Risk Papillary Thyroid Carcinoma. Oropharyngeal Necrotizing Fasciitis in a Previously Healthy Patient. Polygenic Score for Clinicopathologic Features and Survival Outcomes in Papillary Thyroid Carcinoma. Firm Gingival Enlargement in the Anterior Maxilla.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1